These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23228962)

  • 41. Reduced ING1b gene expression plays an important role in carcinogenesis of non-small cell lung cancer patients.
    Kameyama K; Huang CL; Liu D; Masuya D; Nakashima T; Sumitomo S; Takami Y; Kinoshita M; Yokomise H
    Clin Cancer Res; 2003 Oct; 9(13):4926-34. PubMed ID: 14581367
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.
    Zhang JG; Guo JF; Liu DL; Liu Q; Wang JJ
    J Thorac Oncol; 2011 Apr; 6(4):671-8. PubMed ID: 21270667
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MiR-512-5p induces apoptosis and inhibits glycolysis by targeting p21 in non-small cell lung cancer cells.
    Chu K; Gao G; Yang X; Ren S; Li Y; Wu H; Huang Y; Zhou C
    Int J Oncol; 2016 Feb; 48(2):577-86. PubMed ID: 26648284
    [TBL] [Abstract][Full Text] [Related]  

  • 44. mir-660-p53-mir-486 Network: A New Key Regulatory Pathway in Lung Tumorigenesis.
    Borzi C; Calzolari L; Centonze G; Milione M; Sozzi G; Fortunato O
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28124991
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Matrix metalloproteinase 13: a potential intermediate between low expression of microRNA-125b and increasing metastatic potential of non-small cell lung cancer.
    Yu X; Wei F; Yu J; Zhao H; Jia L; Ye Y; Du R; Ren X; Li H
    Cancer Genet; 2015 Mar; 208(3):76-84. PubMed ID: 25772251
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The presence of Merkel cell polyomavirus is associated with deregulated expression of BRAF and Bcl-2 genes in non-small cell lung cancer.
    Lasithiotaki I; Antoniou KM; Derdas SP; Sarchianaki E; Symvoulakis EK; Psaraki A; Spandidos DA; Stathopoulos EN; Siafakas NM; Sourvinos G
    Int J Cancer; 2013 Aug; 133(3):604-11. PubMed ID: 23355004
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Decreased expression of microRNA-375 in nonsmall cell lung cancer and its clinical significance.
    Li Y; Jiang Q; Xia N; Yang H; Hu C
    J Int Med Res; 2012; 40(5):1662-9. PubMed ID: 23206448
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of MAGE-A expression in resected non-small cell lung cancer in relation to clinicopathologic features and mutational status of EGFR and KRAS.
    Ayyoub M; Memeo L; Alvarez-Fernández E; Colarossi C; Costanzo R; Aiello E; Martinetti D; Valmori D
    Cancer Immunol Res; 2014 Oct; 2(10):943-8. PubMed ID: 24866168
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Direct repression of the oncogene CDK4 by the tumor suppressor miR-486-5p in non-small cell lung cancer.
    Shao Y; Shen YQ; Li YL; Liang C; Zhang BJ; Lu SD; He YY; Wang P; Sun QL; Jin YX; Ma ZL
    Oncotarget; 2016 Jun; 7(23):34011-21. PubMed ID: 27049724
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MicroRNA-148b is a potential prognostic biomarker and predictor of response to radiotherapy in non-small-cell lung cancer.
    Wang R; Ye F; Zhen Q; Song T; Tan G; Chu W; Zhang Y; Lv B; Zhao X; Liu J
    J Physiol Biochem; 2016 Jun; 72(2):337-43. PubMed ID: 27083571
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MiR-516a-5p inhibits the proliferation of non-small cell lung cancer by targeting HIST3H2A.
    Ye XY; Xu L; Lu S; Chen ZW
    Int J Immunopathol Pharmacol; 2019; 33():2058738419841481. PubMed ID: 30966836
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prospective molecular marker analyses of EGFR and KRAS from a randomized, placebo-controlled study of erlotinib maintenance therapy in advanced non-small-cell lung cancer.
    Brugger W; Triller N; Blasinska-Morawiec M; Curescu S; Sakalauskas R; Manikhas GM; Mazieres J; Whittom R; Ward C; Mayne K; Trunzer K; Cappuzzo F
    J Clin Oncol; 2011 Nov; 29(31):4113-20. PubMed ID: 21969500
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MicroRNA-133b inhibits the growth of non-small-cell lung cancer by targeting the epidermal growth factor receptor.
    Liu L; Shao X; Gao W; Zhang Z; Liu P; Wang R; Huang P; Yin Y; Shu Y
    FEBS J; 2012 Oct; 279(20):3800-12. PubMed ID: 22883469
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Curcumin promotes apoptosis by activating the p53-miR-192-5p/215-XIAP pathway in non-small cell lung cancer.
    Ye M; Zhang J; Zhang J; Miao Q; Yao L; Zhang J
    Cancer Lett; 2015 Feb; 357(1):196-205. PubMed ID: 25444916
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Isolation of miRNAs that target EGFR mRNA in human lung cancer.
    Yamaguchi G; Takanashi M; Tanaka M; Fujita K; Ohira T; Kuroda M; Ikeda N
    Biochem Biophys Res Commun; 2012 Apr; 420(2):411-6. PubMed ID: 22426479
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PTEN mutations and relationship to EGFR, ERBB2, KRAS, and TP53 mutations in non-small cell lung cancers.
    Jin G; Kim MJ; Jeon HS; Choi JE; Kim DS; Lee EB; Cha SI; Yoon GS; Kim CH; Jung TH; Park JY
    Lung Cancer; 2010 Sep; 69(3):279-83. PubMed ID: 20018398
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
    Yang J; Liu H; Wang H; Sun Y
    Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Downregulation of hsa-microRNA-204-5p and identification of its potential regulatory network in non-small cell lung cancer: RT-qPCR, bioinformatic- and meta-analyses.
    Liang CY; Li ZY; Gan TQ; Fang YY; Gan BL; Chen WJ; Dang YW; Shi K; Feng ZB; Chen G
    Respir Res; 2020 Feb; 21(1):60. PubMed ID: 32102656
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PELI3 mediates pro-tumor actions of down-regulated miR-365a-5p in non-small cell lung cancer.
    He Y; Shi Y; Liu R; Wang Z; Wang B; Li S; Zhang H
    Biol Res; 2019 Apr; 52(1):24. PubMed ID: 30995936
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epidermal growth factor receptor and Kras gene expression: reliability of mutational analysis on cytological samples.
    Bozzetti C; Negri FV; Azzoni C; Naldi N; Nizzoli R; Bortesi B; Zobbi V; Bottarelli L; Tiseo M; Silini EM; Ardizzoni A
    Diagn Cytopathol; 2013 Jul; 41(7):595-8. PubMed ID: 22833420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.